| 1 |
26274696 | Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine. | 2016 Feb |
1 |
| 2 |
23953553 | A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients. | 2013 Jul-Aug |
6 |
| 3 |
21240873 | Good outcomes with cyclosporine very low exposure with everolimus high exposure in renal transplant patients. | 2011 Sep-Oct |
1 |
| 4 |
19458944 | The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients. | 2009 Jul |
4 |
| 5 |
19460557 | Does everolimus associated with a low dose of cyclosporine in long-term cardiac transplant recipients improve renal function? Initial experience. | 2009 May |
2 |
| 6 |
19935373 | Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. | 2009 Nov 27 |
1 |
| 7 |
17181650 | 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. | 2007 Jan |
3 |